Bladder Cancer
Prostate Cancer
EAU Edu Platform on Kidney Cancer
Home
Articles
Article of the Month
Editorials
Videos
Webcasts
Education
E-courses
Webinars
Online curriculum
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorials
Videos
Webcasts
Education
Terug
E-courses
Webinars
Online curriculum
Guidelines
Events
Upcoming event
41st Annual EAU Congress
Home
/
Webcasts
Back
EAU2025
ERUS2024
UROonco2024
EAU 2023
EMUC 22
EAU 2022
EAU21
ESOU21
EMUC20
EAU 20
ESOU20
EMUC 19
RCC 19
ESOU19
EMUC18
Filter
Tags
Article of the Month
,
ASCO GU22
,
ASCO21
,
AUA21
,
Cabozantinib
,
Carcinoma
,
Chronic kidney disease
,
Cryosurgery
,
cystic masses
,
EAU
,
EAU21
,
EAU22
,
EMUC21
,
EMUC22
,
ERUS22
,
ESMO21
,
ESMO25
,
expert interview
,
Frail patient
,
Glomerular filtration rate
,
Guidelines
,
IMDC risk model
,
Kidney cancer
,
Laparoscopy
,
Lymph node metastases
,
Lymph nodes
,
Metastasectomy
,
Mortality
,
Neoplasm metastasis
,
Neoplasm recurrence
,
Nephrectomy
,
Nephron-sparing surgery
,
Nivolumab
,
Overall survival
,
Partial nephrectomy
,
Prognostication
,
Radical nephrectomy
,
Radical surgery
,
RCC
,
Renal cancer
,
Renal cell
,
Renal cell carcinoma
,
Renal Cell Carcinoma guidelines
,
Renal cryoablation
,
Renal function
,
Renal Transplantation
,
Renorrhaphy
,
Robotic
,
Robotic prostatectomy
,
Robotic surgery
,
stereotactic body radiation therapy
,
Survival outcome
,
Suture
,
Targeted therapies
,
Treatment response
,
Urological surgery
,
UROonco24
,
UROonco25
,
UROwebinar
,
Webinar
Show all
Quality of life with open vs robotic-assisted partial nephrectomy (OpeRa) in patients with intermediate/high-complexity renal tumours
Watch now
89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma – results from phase 3 ZIRCON study
Watch now
89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma – results from phase 3 ZIRCON study – Discussant
Watch now
ESU course 2: Partial nephrectomy I
Watch now
Recent advances in the first-line management of advanced RCC
Watch now
New trial results- Adjuvant therapies in high-risk RCC
Watch now
Multidisciplinary case discussion: First-line treatment in mRCC
Watch now
New trial results – Opera
Watch now
(Neo)adjuvant immunotherapy in renal cancer
Watch now
RAPN for endophytic tumor with rainbow technology
Watch now
Case presentation – Risk stratification: Using circulating ctDNA to stage renal cancer
Watch now
State-of-the-art lecture Patient engagement is a potential blockbuster treatment that urologists should prescribe for their cancer patients
Watch now
Previous
Next
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
I agree
Read More